Luna Innovations Inc (LUNA)

INDUSTRIALS: AEROSPACE & DEFENSE
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

301 FIRST STREET SW ROANOKE, VA 24011

Luna Innovations Incorporated engages in the research development and commercialization of technologies in the areas of molecular technology solutions and sensing solutions. The company operates through two divisions Technology Development and Products.

Data as of 2021-01-23
Market Cap354.638 Million Shares Outstanding30.838 Million Avg 30-day Volume302.981 Thousand
P/E Ratio66.2 Dividend Yield EPS0.17
Price/Sales6.247 Price cash flow ratio95.7 Price free cash flow ratio-563.7
Book Value2.38 Price to Tangible Book6.46 Alpha0.03
Short Interest Ratio % Short Interest to Float R-squared0.130593
BETA1.22348 52-week High/Low11.8 / 4.5 Stddev0.148978
View SEC Filings from LUNA instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 70 69 1.45% 24 (1.58%) 23 (1.49%) 4.35%
13F shares: 13.16 Million 13.537 Million -2.79% 7.29 Million 7.395 Million -1.42%
% Ownership 42.7278 43.9533 -2.79% 23.6704 24.0117 -1.42%
New Positions: 11 22 -50.0% 6 4 50.0%
Increased Positions 24 24 0.0% 10 9 11.11%
Closed Positions 8 20 -60.0% 5 9 -44.44%
Reduced Positions 24 17 41.18% 8 10 -20.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LUNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LUNA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GRAEFF SCOTT A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
593,661 2021-01-08 3

NESTRO GENE CHIEF FINANCIAL OFFICER

  • Officer
58,742 2021-01-08 2

ROEDEL RICHARD

  • Director
0 2021-01-04 5

PHELPS BARRY

  • Director
0 2021-01-04 5

VITALE MARY BETH

  • Director
0 2021-01-04 5

ANDERSON N LEIGH

  • Director
0 2020-05-11 1

PASTOR DONALD

  • Director
149,505 2020-05-11 1

SPIEGEL GARY

  • Director
67,569 2020-05-11 1

WILLIAMSON JOHN B III

  • Director
0 2020-04-01 1

WISE MICHAEL W.

  • Director
332,200 2020-01-12 0

CARILION CLINIC

  • 10% Owner
864,330 2019-09-04 0

MESSICK DALE E CHIEF FINANCIAL OFFICER

  • Officer
312,932 2019-06-14 0

CHUNG MY E. PRESIDENT & CEO

  • Officer
  • Director
584,500 2017-06-12 0

CORINGRATO ED J JR.

  • Director
24,271 2015-06-30 0

DALHOUSE WARNER

  • Director
0 2015-04-01 0

WILKIN NEIL D JR

  • Director
0 2014-07-01 0

KEMPER TALFOURD HAAS JR. VP & GENERAL COUNSEL

  • Officer
66,412 2014-06-11 0

MURPHY KENT A

  • 10% Owner
No longer subject to file 2014-01-23 0

FROGGATT MARK CHIEF TECHNOLOGY OFFICER

  • Officer
34,500 2013-03-28 0

MURPHY EDWARD G

  • Director
0 2012-07-02 0

COOL JONATHAN

  • Director
38,377 2012-01-03 0

KILBERG BOBBIE G

  • Director
11,320 2009-07-01 0

DANIELS MICHAEL A

  • Director
0 2009-07-01 0

BACKUS JOHN G

  • Director
0 2009-04-01 0

PLOWMAN C BENSON SR VP, CORP BUS DEVELOPMENT

  • Officer
100,000 2008-08-01 0

MELLER SCOTT A PRES., TECHNOLOGY DEVELOPMENT

  • Officer
27,433 2008-06-27 0

LENK ROBERT P PRESIDENT, LUNA NANOWORKS DIV

  • Officer
0 2008-02-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GRAEFF SCOTT A - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-11 17:09:58 -0500 2021-01-08 F 11,412 $9.72 d 593,661 direct 1.4837 12.6607 12.6607 6 0.0 1

NESTRO GENE - Officer CHIEF FINANCIAL OFFICER

2021-01-11 17:09:01 -0500 2021-01-08 F 1,841 $9.72 d 58,742 direct 1.4837 12.6607 12.6607 6 0.0 1

ROEDEL RICHARD - Director

2021-01-05 17:15:48 -0500 2021-01-04 A 1,659 $9.42 a 54,823 direct

VITALE MARY BETH - Director

2021-01-05 17:14:59 -0500 2021-01-04 A 995 $9.42 a 18,988 direct

PHELPS BARRY - Director

2021-01-05 17:13:54 -0500 2021-01-04 A 995 $9.42 a 61,404 direct

ROEDEL RICHARD - Director

2021-01-05 17:15:48 -0500 2021-01-04 A 106 $9.42 a 55,036 direct

VITALE MARY BETH - Director

2021-01-05 17:14:59 -0500 2021-01-04 A 106 $9.42 a 19,386 direct

PHELPS BARRY - Director

2021-01-05 17:13:54 -0500 2021-01-04 A 106 $9.42 a 61,802 direct

ROEDEL RICHARD - Director

2021-01-05 17:15:48 -0500 2021-01-04 A 106 $9.42 a 54,929 direct

VITALE MARY BETH - Director

2021-01-05 17:14:59 -0500 2021-01-04 A 292 $9.42 a 19,280 direct

PHELPS BARRY - Director

2021-01-05 17:13:54 -0500 2021-01-04 A 292 $9.42 a 61,696 direct

GRAEFF SCOTT A - Director - Officer CHIEF EXECUTIVE OFFICER

2020-12-08 17:14:34 -0500 2020-12-04 F 7,517 $9.97 d 605,073 direct 4.0449 5.8427 26.4045 29.2135 30 -1.0112 3

NESTRO GENE - Officer CHIEF FINANCIAL OFFICER

2020-12-04 17:09:06 -0500 2020-12-02 F 5,017 $9.71 d 60,583 direct -2.7245 -4.5409 13.6226 14.9344 30 -11.0999 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments